semaglutide fda lawsuit Compound versions of GLP-1 drugs for weight loss halted by ofa semaglutide lawsuit As of

Can they work together, or is it best to keep them separate

Choose Ozempic (Semaglutide) If: You have type 2 diabetes and established cardiovascular disease semaglutide has a proven cardiovascular benefit (SUSTAIN-6 trial) You have pre-existing diabetic retinopathy requiring more gradual glucose reduction You have chronic kidney disease semaglutide has an approved kidney-protective indication Your insurance covers semaglutide but not tirzepatide Choose Mounjaro (Tirzepatide) If: Maximum weight loss is your primary goal the data consistently and significantly favours tirzepatide You have type 2 diabetes with persistently poor blood glucose control Your insurance or savings programme makes tirzepatide accessible at a similar cost You have PCOS with significant insulin resistance the dual GLP-1/GIP mechanism produces particularly meaningful improvements in HOMA-IR

The stomach issues

Food and Drug Administration has added blocked intestines as a possible side effect for anyone taking the diabetes drug Ozempic, which many people are also using for weight loss